INC Research Rated "Top CRO" by Investigative Sites Globally
(Thomson Reuters ONE) -
Company achieves top overall ranking in 2013 CenterWatch Global Investigative
Site Relationship Survey, receiving the highest "excellent" scores in six out of
seven working relationship categories among all CROs included in the survey
Raleigh, N.C., May 1, 2013 - INC Research, LLC, a therapeutically focused global
clinical research organization (CRO) with a Trusted Process(®) for delivering
reliable results, is ranked the "Top CRO" in the 2013 CenterWatch Global
Investigative Site Relationship Survey. Results of the survey were published
earlier today by CenterWatch, with INC Research receiving the highest
"excellent" scores in six out of seven working relationship categories among all
CROs included in the survey, a reflection of the Company's continued focus on
developing strategic relationships with sites.
"Quality relationships with investigative sites around the world are a critical
success factor in delivering clinical trial results on time and on budget for
our customers," said Jamie Macdonald, Chief Executive Officer. "This recognition
is a testament to the value we provide to our partners through our people and
our approach to clinical development. We are pleased that investigative sites
worldwide have validated our focus on building long-lasting relationships."
INC Research was rated a top-three CRO in all 36 individual project attributes
across the seven relationship categories included in the survey. The Company
received some of its highest scores in maintaining a professional staff -
monitors, medical experts and administrative support - and for being well
organized and prepared in supporting studies. The 2013 survey also asked sites
to evaluate CROs for the first time on their overall reputation in the industry,
with INC being one of only four global CROs to rank in the top five in both
reputation and direct working relationship quality.
CenterWatch conducted the biannual global survey of investigative sites during
November/December 2012 and January 2013, soliciting online responses from
principal investigators, sub-investigators and study coordinators about the
quality and effectiveness of their relationships with the CROs they have worked
with in the past two years. A total of 2,032 sites worldwide completed the
survey - the highest response rate ever achieved for this survey - which
evaluated the performance of CROs across 36 specific relationship attributes.
Rankings are based on a combination of two measures: an overall relationship
quality rating based on "excellent" scores from sites, and the frequency with
which companies placed among the top-three rated CROs across the 36 relationship
attributes measured.
INC Research's rating as the top CRO to work with is a direct reflection of the
Company's dedication to providing optimal service to the investigators engaged
in its studies. The Company has dedicated global departments focused
specifically on enhancing site relationships and works with sites in a
collaborative partnership to
improve cycle times and standardize start-up activities to drive efficiency.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development programs
of the highest integrity. Pharmaceutical and biotechnology companies look to INC
Research for a complete range of customized Phase I through Phase IV programs in
all therapeutic areas and innovative pediatric and women's health trials. The
company's Trusted Process(®) methodology and therapeutic foresight lead
customers to more confident, better-informed drug and device development
decisions. INC Research is headquartered in Raleigh, NC. For more information,
please visit www.incresearch.com or follow us at (at)inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1698476]
Unternehmensinformation / Kurzprofil:
Datum: 01.05.2013 - 19:43 Uhr
Sprache: Deutsch
News-ID 255159
Anzahl Zeichen: 4784
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 299 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Rated "Top CRO" by Investigative Sites Globally"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
